107 related articles for article (PubMed ID: 26544726)
21. Marine Microorganism-Derived Macrolactins Inhibit Inflammatory Mediator Effects in LPS-Induced Macrophage and Microglial Cells by Regulating BACH1 and HO-1/Nrf2 Signals through Inhibition of TLR4 Activation.
Kim EN; Gao M; Choi H; Jeong GS
Molecules; 2020 Feb; 25(3):. PubMed ID: 32033079
[TBL] [Abstract][Full Text] [Related]
22. Novel agent #2714 potently inhibits lung cancer growth by suppressing cell proliferation and by inducing apoptosis in vitro and in vivo.
Lu W; Sun Q; Chen B; Li Y; Xu Y; Wang S
Mol Med Rep; 2019 Jun; 19(6):4788-4796. PubMed ID: 30942420
[TBL] [Abstract][Full Text] [Related]
23. (-)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) Quinic Acid Inhibits the Function of Myeloid-Derived Suppressor Cells to Enhance the Efficacy of Anti-PD1 against Colon Cancer.
Lin H; Wu Y; Chen J; Huang S; Wang Y
Pharm Res; 2018 Jul; 35(9):183. PubMed ID: 30062658
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma.
Jin J; Hwang K; Joo JD; Han JH; Kim CY
Oncotarget; 2018 Jan; 9(2):2140-2147. PubMed ID: 29416760
[TBL] [Abstract][Full Text] [Related]
25. Microbial diversity of saline environments: searching for cytotoxic activities.
Díaz-Cárdenas C; Cantillo A; Rojas LY; Sandoval T; Fiorentino S; Robles J; Ramos FA; Zambrano MM; Baena S
AMB Express; 2017 Dec; 7(1):223. PubMed ID: 29273919
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model.
Jin J; Choi SH; Lee JE; Joo JD; Han JH; Park SY; Kim CY
Oncol Lett; 2017 May; 13(5):3767-3773. PubMed ID: 28529591
[TBL] [Abstract][Full Text] [Related]
27. Calculation of a First-In-Man Dose of 7-
Noh K; Kang ΨW
Biomol Ther (Seoul); 2017 Nov; 25(6):648-658. PubMed ID: 28274094
[TBL] [Abstract][Full Text] [Related]
28. Alcohol Injury Damages Intestinal Stem Cells.
Lu R; Voigt RM; Zhang Y; Kato I; Xia Y; Forsyth CB; Keshavarzian A; Sun J
Alcohol Clin Exp Res; 2017 Apr; 41(4):727-734. PubMed ID: 28195397
[TBL] [Abstract][Full Text] [Related]
29. Potential role of Wnt/β-catenin signaling in blastic transformation of chronic myeloid leukemia: cross talk between β-catenin and BCR-ABL.
Hu J; Feng M; Liu ZL; Liu Y; Huang ZL; Li H; Feng WL
Tumour Biol; 2016 Nov; ():. PubMed ID: 27817074
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
Zhao L; Mao Y; Zhou J; Zhao Y; Cao Y; Chen X
Am J Cancer Res; 2016; 6(2):387-402. PubMed ID: 27186411
[TBL] [Abstract][Full Text] [Related]
31. Targeting Tankyrase to Fight WNT-dependent Tumours.
Thorvaldsen TE
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):81-88. PubMed ID: 28371398
[TBL] [Abstract][Full Text] [Related]
32. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.
He L; Lu N; Dai Q; Zhao Y; Zhao L; Wang H; Li Z; You Q; Guo Q
Toxicology; 2013 Oct; 312():36-47. PubMed ID: 23907061
[TBL] [Abstract][Full Text] [Related]
33. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
[TBL] [Abstract][Full Text] [Related]
34. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
35. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
36. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
